Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Feb 13;2(1):e200028.
doi: 10.1148/ryct.2020200028. eCollection 2020 Feb.

Chest Imaging Appearance of COVID-19 Infection

Weifang Kong  1 , Prachi P Agarwal  1
Affiliations
Case Reports

Chest Imaging Appearance of COVID-19 Infection

Weifang Kong et al. Radiol Cardiothorac Imaging. .

Abstract

Coronavirus disease 2019 (COVID-19) (previously known as novel coronavirus [2019-nCoV]), first reported in China, has now been declared a global health emergency by the World Health Organization. As confirmed cases are being reported in several countries from all over the world, it becomes important for all radiologists to be aware of the imaging spectrum of the disease and contribute to effective surveillance and response measures. © RSNA, 2020 See editorial by Kay and Abbara in this issue.

PubMed Disclaimer

Conflict of interest statement

Disclosures of Conflicts of Interest: W.K. disclosed no relevant relationships. P.P.A. disclosed no relevant relationships.

Figures

(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
Figure 1a:
(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
Figure 1b:
(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
Figure 1c:
(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
Figure 1d:
(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
Figure 1e:
(a) Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. (b) Axial and (c) sagittal chest CT images demonstrate peripheral right lower lobe ground-glass opacities. Follow-up (d) axial and (e) sagittal chest CT images 2 days later show improvement in the extent of ground-glass opacities, with more subpleural curvilinear lines (arrows).
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
Figure 2a:
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
Figure 2b:
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
Figure 2c:
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
Figure 2d:
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
Figure 2e:
(a) Axial chest CT image at presentation shows a small solitary nodular ground-glass opacity in left upper lobe (arrow). (b, c) Note the progression of airspace disease 3 days later, with new foci of ground-glass opacities (black arrows, b, c), as well as developing consolidation (white arrow). Additionally, there is higher peripheral attenuation with ground-glass opacities more centrally representing the reversed halo sign (curved arrows, c). (d, e) Further increase in extent of ground glass changes with new cavity in right lung (arrow, d) as well as new areas of consolidation (arrow, e) are seen on CT images 5 days after presentation.
(a) Note the peripheral predominant airspace opacities with a reversed halo pattern in the left upper lobe (arrow). (b, c) Organizing changes with increasing attenuation are noted on follow-up CT images.
Figure 3a:
(a) Note the peripheral predominant airspace opacities with a reversed halo pattern in the left upper lobe (arrow). (b, c) Organizing changes with increasing attenuation are noted on follow-up CT images.
(a) Note the peripheral predominant airspace opacities with a reversed halo pattern in the left upper lobe (arrow). (b, c) Organizing changes with increasing attenuation are noted on follow-up CT images.
Figure 3b:
(a) Note the peripheral predominant airspace opacities with a reversed halo pattern in the left upper lobe (arrow). (b, c) Organizing changes with increasing attenuation are noted on follow-up CT images.
(a) Note the peripheral predominant airspace opacities with a reversed halo pattern in the left upper lobe (arrow). (b, c) Organizing changes with increasing attenuation are noted on follow-up CT images.
Figure 3c:
(a) Note the peripheral predominant airspace opacities with a reversed halo pattern in the left upper lobe (arrow). (b, c) Organizing changes with increasing attenuation are noted on follow-up CT images.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization . Novel Coronavirus (2019-nCoV) Situation report-15. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed February 2020.
    1. 2019 Novel Coronavirus (2019-nCoV) in the U.S. Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html. Accessed February 2020.
    1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020 Jan 30 [Epub ahead of print]. - PMC - PubMed
    1. Lei J, Li J, Li X, Qi X. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology 2020 Jan 31:200236 [Epub ahead of print]. - PMC - PubMed
    1. Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology 2020 Feb 4:200230 [Epub ahead of print]. - PMC - PubMed

Publication types

-